• Welcome to DZIF

    It is the 21st century and infections are still a major challenge for medicine. What is our recourse as germs become increasingly resistant to antibiotics? What can we do to prevent the spread of a pathogen? The researchers at the German Center for Infection Research (DZIF) are tackling these and many other issues.

  • DZIF scientist in the Ebola crisis region

    DZIF infectious disease and tropical medicine specialist Günter Fröschl, from Munich, spent two months in Liberia, to help with the largest Ebola epidemic seen to date. We spoke to him about his work in the crisis region.


  • Researchers discover novel antibiotic agent

    DZIF-Scientist Dr Tanja Schneider and her group at the University of Bonn participated in a hopeful discovery: Teixobactin is the name of a new antibiotic compound which is effective against a broad spectrum of pathogens. Photo: University of Bonn
    Press Release

  • Tuberculosis: Multidrug resistance is a major challenge

    DZIF Professor Stefan Niemann, Forschungszentrum Borstel, explains which problems need to be solved in optimising new drugs against tuberculosis.

  • ECCMID 2015

    The European Congress of Clinical Microbiology and Infectious Diseases will take place 25 to 28 April 2015 in Copenhagen, Denmark. The DZIF will be present.
    ECCMID 2015


  • 12 March 2015 - PRESS RELEASE

    Cologne Infectologist honoured

    DZIF researcher Oliver Cornely has been elected as a Fellow of the American Academy of Microbiology (AAM) in honour of his achievements in the field of life-threatening infections in immunocompromised patients. more ]